XML 55 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation and Benefit Plans (Tables)
12 Months Ended
Apr. 01, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Stock Units Activities
RSUs
(In millions, except per share and year data)
Number of
Shares
Weighted-
Average
Grant Date Fair Value
Outstanding as of April 2, 2021$20.62 
Granted$22.53 
Vested(2)$20.89 
Forfeited(1)$21.07 
Outstanding as of April 1, 2022$21.80 
Schedule of PRUs Activity
PRUs
(In millions, except per share and year data)Number of
Shares
Weighted-
Average
Grant Date Fair Value
Outstanding and unvested as of April 2, 2021$27.50 
Granted$28.68 
Forfeited(1)$28.40 
Unvested at April 1, 2022$28.50 
Vested and unreleased as of April 1, 2022— 
Outstanding as of April 1, 2022
Schedule Of PRUs Valuation Assumptions The valuation and the underlying weighted-average assumptions for PRUs are summarized below:
 Year Ended
April 1, 2022April 2, 2021April 3, 2020
Expected term3.9 years2.7 years1.9 years
Expected volatility37.6 %42.5 %38.1 %
Risk-free interest rate1.0 %0.2 %1.7 %
Expected dividend yield— %— %1.7 %
Weighted-average grant date fair value of PRUs$28.68$26.39$21.69
Schedule of Stock Option Activities
Stock options
(In millions, except per share and year data)Number of
Shares
Weighted-Average Exercise PriceWeighted-
Average
Remaining Contractual Term
(Years)
Aggregate Intrinsic
Value
Outstanding as of April 1, 2021 (1)
— $5.22 
Granted — $— 
Exercised (1)
— $4.73 
Canceled— $— 
Forfeited and expired (1)
— $7.01 
Outstanding as of April 1, 2022 (1)
— $5.51 
Exercisable as of April 1, 2022 (1)
— $5.51 3.8$
(1) The number of shares is less than 1 million.
Schedule of ESPP Activities
The following table summarizes activity related to the purchase rights issued under the ESPP:
 Year Ended
(In millions)April 1, 2022April 2, 2021April 3, 2020
Shares issued under the ESPP
Proceeds from issuance of shares$13 $14 $39 
Schedule of Stock-based Compensation Expense
The following table summarizes the stock-based compensation expense recognized as a result of these modifications:
Year Ended
(In millions)
April 2, 2021April 3, 2020
Sales and marketing$$
Research and development— 
General and administrative20 
Restructuring and other costs10 20 
Discontinued operations99 
Total stock-based compensation$30 $145 
Total stock-based compensation expense and the related income tax benefit recognized for all of our equity incentive plans in our Consolidated Statements of Operations were as follows:
 Year Ended
(In millions)April 1, 2022April 2, 2021April 3, 2020
Cost of revenues$$$
Sales and marketing19 18 29 
Research and development19 26 30 
General and administrative30 26 58 
Restructuring and other costs— 10 20 
Other income (expense), net— (1)
Total stock-based compensation from continuing operations70 80 140 
Discontinued operations— 172 
Total stock-based compensation expense$70 $81 $312 
Income tax benefit for stock-based compensation expense$(11)$(18)$(55)
Schedule of Employer 401K Contributions Our employer matching contributions to the 401(k) plan were as follows, including contributions to employees of our discontinued operations:
 Year Ended
(In millions)April 1, 2022April 2, 2021April 3, 2020
401(k) matching contributions$$$16